SCHEMBL2454087

SCHEMBL2454087

COC(=O)c1ccccc1OCCOc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.71
KMT2A Q03164 5/20 0.68
MEN1 O00255 4/20 0.68
MAPT P10636 4/20 0.64
RAB9A P51151 1/20 0.64
L3MBTL1 Q9Y468 2/20 0.58
TDP1 Q9NUW8 1/20 0.58
GAA P10253 1/20 0.58
HSP90AA1 P07900 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
HTT P42858 1/20 0.57
KDM4E B2RXH2 3/20 0.55
SLC6A3 Q01959 1/20 0.55
TSHR P16473 1/20 0.55
MAPK10 P53779 1/20 0.55
HSD17B10 Q99714 1/20 0.55
PTK2B Q14289 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9323971 0.87 MAPT (0.57) ALDH1A1KMT2AMEN1MAPTRAB9A
SCHEMBL385973 0.87 HSP90AA1 (0.59) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL28679146 0.84 ALDH1A1 (0.67) ALDH1A1KMT2AMEN1MAPTRAB9A
Benzene SCHEMBL28006415 0.84 MAPT (0.60) ALDH1A1KMT2AMEN1MAPTL3MBTL1
SCHEMBL19973528 0.84 LMNA (0.66) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL536427 0.83 MAPT (0.59) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL6280141 0.83 HSP90AA1 (0.59) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL2452436 0.83 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTRAB9A
SCHEMBL25365376 0.83 NPSR1 (0.63) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL28478929 0.83 ALDH1A1 (0.66) ALDH1A1KMT2AMEN1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022072-B2 Azolylmethylidenehydrazine derivative and use thereof KAKEN PHARMACEUTICAL CO., LTD. (JP) 2011-09-20 US disclosed
US-20100190754-A1 AZOLYLMETHYLIDENEHYDRAZINE DERIVATIVE AND USE THEREOF KAKEN PHARMACEUTICAL CO., LTD. (JP) 2010-07-29 US disclosed
EP-2168951-A1 AZOLYLMETHYLENEHYDRAZINE DERIVATIVE AND USE THEREOF KAKEN PHARMACEUTICAL CO., LTD. (JP) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190754-A1 AZOLYLMETHYLIDENEHYDRAZINE DERIVATIVE AND USE THEREOF ARSA, AHR, HRH2 ALDH1A1 831/4885KMT2A 1190/4885MEN1 2324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.